YOUR QUESTIONS / 05
BPC-157 TB-500 FAQ: What do studies tell us?
Most BPC-157 and TB-500 findings came from animals, and researchers tested the substances apart. These answers show where proof ends for you.
Contents
What are the two substances in the mix?
Where do BPC-157 and TB-500 come from?
BPC-157 is a lab-made piece of a protein found in stomach juice [1]. TB-500 is a short piece cut from the whole protein Thymosin Beta-4 [7]; that whole protein helps cells move. These facts tell you what each substance is, but don't prove that the pair works.
Is the Wolverine peptide blend one tested drug?
No. Wolverine is a common name for mixing BPC-157 with TB-500. Studies haven't set a standard share for either part, and no product is approved [11]; some people call the mix a stack, meaning several substances used together.
Why did researchers study BPC-157 and TB-500?
Animal work on BPC-157 and TB-500 looked at tendons, ligaments, muscle, bone, and wounds [5][6]. Most papers tested one substance by itself, and no fair study has found a benefit from the pair [11]. Animal results can't promise help for your knee.
How do the two substances differ?
BPC-157 comes from a protein in stomach juice. TB-500 is cut from whole Thymosin Beta-4, which helps cells move [2][3]. Their size and the jobs studied are different, so you can't apply a finding for one to the other.
How did each substance seem to affect repair?
What changed after animals received each substance?
BPC-157 led to more small vessels and faster blood return in hurt rat muscle [2]. Whole Thymosin Beta-4, from which TB-500 is cut, helped wounds and blood vessels in animals [6]. The studies give no forecast for your body, since the pair wasn't compared with other care [11].
Why do people put BPC-157 and TB-500 together?
BPC-157 may help blood reach a wound. The whole protein may help repair cells move [2][3]. People hope TB-500 can also move repair cells when paired with BPC-157, but you still don't have proof that TB-500 adds help or which mix is best.
How did whole Thymosin Beta-4 affect cell movement?
TB-500 is a short piece cut from Thymosin Beta-4. In a lab dish, the whole protein joined actin, which gives cells shape and aids movement [3]. Scientists wrote the pairing as 1:1, but the lab count can't tell you that TB-500 will close a wound faster.
What changed in the rat blood-vessel test?
BPC-157 helped small vessels form and blood return in rat tissue [2][3][8]. A separate lab result linked whole Thymosin Beta-4 with cell movement; scientists again wrote its pairing with actin as 1:1. These results don't prove that BPC-157 and TB-500 add help for you when used together.
What did the strongest repair studies find?
Has BPC-157 and TB-500 worked better than other care?
No. A 2025 review looked at 36 BPC-157 studies. Only 1 included a person, and none paired BPC-157 with TB-500 [11]; extra help from BPC-157 is still only a guess.
Has a fair human study tested the mix?
No human study with comparison groups has tried the mix [13]. A few small, early studies concern BPC-157 by itself. The human work sometimes cited for TB-500 used whole Thymosin Beta-4, not TB-500 [4], so you still lack a sound answer about benefit or harm.
What happened in the tendon test behind BPC-157 TB-500?
BPC-157 helped fully cut Achilles tendons join and bear weight in rats [5]. Collagen also formed better; collagen is the tough protein that gives a tendon strength. The test didn't use people or TB-500, so it can't promise the same result for your tendon.
What did separate muscle tests find?
BPC-157 showed signs of repair in animal tissue [2]. A 6-month mouse test of whole Thymosin Beta-4 grew new fibers but did not make the mice stronger [4]. The substances were not given together, so that Thymosin Beta-4 result can't tell you how your muscle would respond to the pair.
Has a BPC-157 TB-500 mix closed wounds in people?
Whole Thymosin Beta-4 helped wounds close in young and old animals [6]. That work also found more small vessels. A separate BPC-157 test found less damage in hurt tissue [2], but no wound study with comparison groups tested the mix [11].
Which harms did studies raise, and what remains unknown?
What risks are known for BPC-157 and TB-500?
No one knows whether either part is safe for people over many years. Whole Thymosin Beta-4 can aid cell movement and vessel growth, which tumors may also use [4]. The concern comes from lab work rather than proof of cancer in people, so read the known and unknown risks as you weigh the pair.
Has TB-500 been shown to cause cancer?
No. Tests in animals and lab dishes linked whole Thymosin Beta-4 with tumor spread and new vessel growth [4]. The tests don't prove that TB-500 causes cancer in people, and human studies haven't shown that the TB-500 piece is safe for you.
What did heart studies test?
The first human safety step, called Phase 1, put whole Thymosin Beta-4 into a vein. People handled amounts up to 1260 milligrams without major short-term harm [14]. That was not the TB-500 piece or the mix; a 6-month mouse test of Thymosin Beta-4 found no better heart function, and no comparison test used TB-500 [4].
What do studies say about timing, mixing, and shots?
What does half-life mean for BPC-157 and TB-500?
Half-life is the time a body needs to clear half an amount. In rats and dogs, BPC-157 had a half-life under 30 minutes [1]. Higher amounts of whole Thymosin Beta-4 stayed in people's blood longer than lower amounts. No test has set that time for TB-500 or for your body [14].
What does a BPC-157 / TB-500 vial marked 10mg tell you?
Labs may provide both substances as dry powders for mixing with germ-free water. The label does not verify its contents, its purity, or the share of each substance. This describes lab handling, not how you would use the mix.
What did animal tests tell us about shots?
One mouse test gave 150 micrograms of whole Thymosin Beta-4 twice each week for 6 months [4]. A microgram is one millionth of a gram. The study did not test TB-500 or set a shot plan for the mix. People call a larger first amount loading and a steady later amount maintenance, but neither plan has beaten other care in a fair study [11].
Have studies set a start-and-stop plan for BPC-157 and TB-500?
No. Fixed vials marked 10 milligrams plus 10 milligrams haven't been proved as a plan for people [11]. An untested label can't set your timing.
How soon could BPC-157 and TB-500 help an injury?
No human test gives a sound answer. Study times run from short animal work to a 6-month mouse test of whole Thymosin Beta-4 [4][11]. Researchers haven't found a starting time for the pair. BPC-157 and TB-500 still have no shared timetable. Any promise of a set number of weeks goes past the proof.
What do FDA and sports rules mean for the pair?
What do FDA and WADA rules say about BPC-157 and TB-500?
FDA has approved neither substance. On September 29, 2023, FDA put BPC-157 in Category 2 under 503A, its rule for medicine made by a local pharmacy for one patient [15]. Category 2 is the safety-concern list for raw drug ingredients. The same update put the short Thymosin Beta-4 piece called TB-500 in Category 2 [16]. WADA, the world group that sets sports drug rules, bars both in tested sport.
Can a pharmacy mix BPC-157 for you?
FDA's page, current as of April 22, 2026, says BPC-157's nomination was withdrawn and no longer lists it in Category 2, but the page does not explain what that lets a local pharmacy do [15]. FDA says this group may carry serious safety risks. While BPC-157 sat in it, FDA's usual policy did not protect a pharmacy that used it from FDA action [17]. Your state may add more limits.
Has FDA approved a Wolverine drug?
No Wolverine drug is approved. BPC-157 and the TB-500 piece went into Category 2 under the FDA 503A one-patient pharmacy rule on September 29, 2023, and FDA now lists both requests as withdrawn [15][16]. The Wolverine legal status and FDA 503A category page explains what that means. It does not offer a way to get the mix.
Which FDA safety group covers Wolverine?
Both parts entered Category 2 under FDA 503A, the one-patient pharmacy rule, on September 29, 2023; FDA's page current as of April 22, 2026 shows both requests withdrawn and no longer places them there [15][16]. FDA says ingredients in this group may carry serious safety risks. The pair has no separate FDA class. It carries the concern attached to both parts.